FundLens
66
Pharma & HealthcareBuy

ICICI Pru Pharma Healthcare And Diagnostics PHD

ICICI Pru · Direct–Growth · rank #3 of 18 by Smart Score

Trailing returns

vs Nifty 500 (index-fund proxy)
1 Year
7.3%
+6.8% vs index
3 Years
25.6%
+13.3% vs index
5 Years
16.5%
+4.6% vs index
Since launch
21.5%

Why this score

ICICI Pru Pharma Healthcare And Diagnostics PHD scores 66/100 — #3 of 18 Pharma & Healthcare fund (Buy). It stands out for 3y return and 5y return — beating 85% of peers on 3y return. The main drag is its expense ratio (better than only 17% of peers).

Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.

3Y return25.56% · 85th percentile in category
5Y return16.52% · 83rd percentile in category
Sharpe ratio1.25 · 85th percentile in category
Fund size6624.58 Cr · 92nd percentile in category
Expense ratio1.31% · 17th percentile in category
Volatility16.92 · 21st percentile in category

Other Pharma & Healthcare funds